Bevacizumab plus cisplatin and helical tomotherapy in treatment of locally advanced nasopharyngeal carcinoma

References

• LeeAWSzeWMAuJSTreatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experienceInt J Radiat Oncol Biol Phys20056141107111615752890
   PubMed Web of Science ®Google Scholar
• BrowmanGPHodsonDIMackenzieRJChoosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysisHead Neck200123757958911400247
   PubMed Web of Science ®Google Scholar
• MarcialVAPajakTFMohiuddinMConcomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Long-term results of the Radiation Therapy Oncology Group study 81-17Cancer1990669186118682224782
   PubMed Web of Science ®Google Scholar
• ForastiereAAGoepfertHMaorMConcurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancerN Engl J Med2003349222091209814645636
   PubMed Web of Science ®Google Scholar
• AdelsteinDJLiYAdamsGLAn intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancerJ Clin Oncol2003211929812506176
   PubMed Web of Science ®Google Scholar
• KesmezacarHAyhanEUnluMCSekerAKaracaSPredictors of mortality in elderly patients with an intertrochanteric or a femoral neck fractureJ Trauma201068115315810.1097/TA.0b013e31819adc50(2010)19797990
   PubMedGoogle Scholar
• National Comprehensive Cancer Network: About NCCN; NCCN Guidelines^® Available from: http://www.nccn.org/professionals/physicians_gls/pdf/head-and-neckAccessed May 25, 2015
   Google Scholar
• FidlerIJCancer metastasisBr Med Bull19914711571771863845
   PubMed Web of Science ®Google Scholar
• FakhrejahaniEToiMAntiangiogenesis therapy for breast cancer: an update and perspectives from clinical trialsJpn J Clin Oncol201444319720724474817
   PubMed Web of Science ®Google Scholar
• KirsteinMMLangeAPrenzlerAMannsMPKubickaSVogelATargeted Therapies in Metastatic Colorectal Cancer: A Systematic Review and Assessment of Currently Available DataOncologist201419111156116825326159
   PubMed Web of Science ®Google Scholar
• LaiGGPensonRTBevacizumab and ovarian cancerDrugs Today (Barc)201147966968121971541
   PubMed Web of Science ®Google Scholar
• HsuHWWallNRHsuehCTCombination antiangiogenic therapy and radiation in head and neck cancersOral oncol2014501192624269532
   PubMed Web of Science ®Google Scholar
• KyzasPACunhaIWIoannidisJPPrognostic significance of vascular endothelial growth factor immunohistochemical expression in head and neck squamous cell carcinoma: a meta-analysisClin Cancer Res20051141434144015746043
   PubMed Web of Science ®Google Scholar
• FuryMGLeeNYShermanEA phase 2 study of bevacizumab with cisplatin plus intensity-modulated radiation therapy for stage III/IVB head and neck squamous cell cancerCancer2012118205008501422415650
   PubMed Web of Science ®Google Scholar
• JainRKNormalization of tumor vasculature: an emerging concept in antiangiogenic therapyScience20053075706586215637262
   PubMed Web of Science ®Google Scholar
• MaBBKamMKLeungSFA phase II study of concurrent cetuximabcisplatin and intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinomaAnn Oncol20122351287129221948811
   PubMed Web of Science ®Google Scholar
• AravantinosGPectasidesDBevacizumab in combination with chemotherapy for the treatment of advanced ovarian cancer: a systematic reviewJ Ovarian Res201475724864163
   PubMed Web of Science ®Google Scholar
• SalamaJKHarafDJStensonKMA randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancersAnn Oncol201122102304230921330337
   PubMed Web of Science ®Google Scholar
• SeiwertTYHarafDJCohenEEPhase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancerJ Clin Oncol200826101732174118375903
   PubMed Web of Science ®Google Scholar
• GardenASHarrisJVokesEEPreliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neckJ Clin Oncol200422142856286415254053
   PubMed Web of Science ®Google Scholar
• LeeNYZhangQPfisterDGAddition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trialLancet Oncol201213217218022178121
   PubMed Web of Science ®Google Scholar
• PfisterDGSuYBKrausDHConcurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigmJ Clin Oncol20062471072107816505426
   PubMed Web of Science ®Google Scholar
• ArgirisAHeronDESmithRPInduction docetaxel, cisplatin, and cetuximab followed by concurrent radiotherapy, cisplatin, and cetuximab and maintenance cetuximab in patients with locally advanced head and neck cancerJ Clin Oncol201028365294530021079141
   PubMed Web of Science ®Google Scholar
• ChanATTeoPMNganRKConcurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trialJ Clin Oncol20022082038204411956263
   PubMed Web of Science ®Google Scholar
• KamMKTeoPMChauRMTreatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experienceInt J Radiat Oncol Biol Phys20046051440145015590175
   PubMed Web of Science ®Google Scholar
• KwongDLPowEHShamJSIntensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary functionCancer200410171584159315378492
   PubMed Web of Science ®Google Scholar
• JohnsonDHFehrenbacherLNovotnyWFRandomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancerJ Clin Oncol200422112184219115169807
   PubMed Web of Science ®Google Scholar
• ArgirisAKotsakisAPHoangTCetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neckAnn Oncol201324122022522898037
   PubMed Web of Science ®Google Scholar